WEBSITECHANGES

Website Changes

---

07/09/2009

Governor Nixon honors brain tumor patients in Missouri by signing House Bill 683

---

07/03/2009

Study identifies biomarker that safely monitors tumor response to new brain cancer treatment

---

07/03/2009

Need help voting for the Grey Ribbon Crusade!

---

07/02/2009

New Tactics Promising for Prostate, Brain and Pancreatic Cancer

---

06/30/2009

The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry.

---

06/30/2009

Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma.

---

06/30/2009

Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment.

---

06/25/2009

FOURTH ANNUAL HAVE A CHANCE WALK TO FIGHT BRAIN TUMORS ANNOUNCED FOR OCTOBER 18th, 2009

---

06/25/2009

Antigenics Announces Expansion of Investigator-Sponsored Study for Glioma

---

06/24/2009

ANNUAL NEUROSURGERY CHARITY SOFTBALL TOURNAMENT

---

06/20/2009

Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study.

---

06/20/2009

Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas

---

06/20/2009

Bevacizumab (Avastin) and chemotherapy for recurrent glioblastoma: a single-institution experience.

---

06/20/2009

Decreased rate of infection in glioblastoma patients with allelic loss of chromosome 10q.

---

06/20/2009

Very late relapses in glioblastoma long-term survivors.

---

06/20/2009

A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation.

---

06/20/2009

Randomized Phase II Trial of Chemoradiotherapy Followed by Either Dose-Dense or Metronomic Temozolomide for Newly Diagnosed Glioblastoma.

---

06/20/2009

Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab (Avastin)

---

06/14/2009

Added a translation widget to the bottom of every page!

---

06/13/2009

Added more videos!

---

06/12/2009

UPDATE 1-Exelixis brain cancer drug response rates lowered

---

06/12/2009

Norton launches new brain-tumor program

---

06/12/2009

Neurobiological Technologies` Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program

---

06/12/2009

Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy.

---

06/12/2009

Randomized Phase II Trial of Chemoradiotherapy Followed by Either Dose-Dense or Metronomic Temozolomide for Newly Diagnosed Glioblastoma

---